Literature DB >> 3130123

Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy.

A R Lloyd-Thomas1, I Wright, T A Lister, C J Hinds.   

Abstract

The mortality of patients admitted to intensive care units with haematological malignancy is high. A humane approach to the management of the critically ill as well as efficient use of limited resources requires careful selection of those patients who are most likely to benefit from intensive care. To delineate more accurately the factors influencing outcome in these patients the records of 60 consecutive admissions to the intensive care unit (37 male, 23 female) with haematological malignancy were reviewed retrospectively. Fifty patients were in acute respiratory failure, most commonly (34 patients) with a combination of pneumonia and septicaemic shock. The severity of the acute illness was assessed by the APACHE II (acute physiology and chronic health evaluation II) score and number of organ systems affected. Thirteen patients survived to leave hospital. The mortality of patients with haematological malignancy was consistently higher than predicted from a large validation study of APACHE II in a mixed population of critically ill patients. Moreover, no patient with an APACHE II score of greater than 26 survived. Mortality among the 22 patients with relapsed malignancy (21 deaths), was significantly higher than among the 35 patients at first presentation (26 deaths). On discharge from the intensive care unit all survivors had responded well to chemotherapy and had normal or raised peripheral white cell counts. They included seven patients who had recovered from leucopenia (white cell count less than 0.5 X 10(9)/l). In contrast, 36 of the 47 patients who died were leucopenic at the time of death. The overall mortality of critically ill patients with haematological malignancy is higher than equivalently ill patients without cancer. The dysfunction of an increasing number of organ systems, an APACHE II score of greater than 30, failure of the malignancy to respond to chemotherapy, and persistent leucopenia all point to a poor outcome.

Entities:  

Mesh:

Year:  1988        PMID: 3130123      PMCID: PMC2545556          DOI: 10.1136/bmj.296.6628.1025

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

Review 2.  "Bad risk" non-Hodgkin lymphomas.

Authors:  A Horwich; M Peckham
Journal:  Semin Hematol       Date:  1983-01       Impact factor: 3.851

3.  Short-term treatment for acute myelogenous leukaemia.

Authors:  R Bell; A Z Rohatiner; M L Slevin; J M Ford; H S Dhaliwal; G Henry; B G Birkhead; J A Amess; J S Malpas; T A Lister
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-24

4.  The inverse relationship between cost and survival in the critically ill cancer patient.

Authors:  A D Turnbull; G Carlon; R Baron; W Sichel; C Young; W Howland
Journal:  Crit Care Med       Date:  1979-01       Impact factor: 7.598

5.  Respiratory failure in cancer patients.

Authors:  R M Snow; W C Miller; D L Rice; M K Ali
Journal:  JAMA       Date:  1979-05-11       Impact factor: 56.272

6.  Survival of patients with cancer in a medical critical care unit.

Authors:  M J Hauser; J Tabak; H Baier
Journal:  Arch Intern Med       Date:  1982-03

Review 7.  The treatment of acute myelogenous leukemia in adults.

Authors:  T A Lister; A Z Rohatiner
Journal:  Semin Hematol       Date:  1982-07       Impact factor: 3.851

8.  Acute respiratory failure in severe hematologic disorders.

Authors:  R Estopa; A Torres Marti; N Kastanos; A Rives; A Agusti-Vidal; C Rozman
Journal:  Crit Care Med       Date:  1984-01       Impact factor: 7.598

9.  Intensive therapy for life-threatening medical complications of haematological malignancy.

Authors:  A R Lloyd-Thomas; H S Dhaliwal; T A Lister; C J Hinds
Journal:  Intensive Care Med       Date:  1986       Impact factor: 17.440

10.  Relationship between acute physiologic derangement and risk of death.

Authors:  W A Knaus; D P Wagner; E A Draper
Journal:  J Chronic Dis       Date:  1985
View more
  24 in total

1.  Predicting outcome in intensive therapy units--a comparison of Apache II with subjective assessments.

Authors:  R J Marks; R S Simons; R A Blizzard; D R Browne
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

2.  Can we still refuse ICU admission of patients with hematological malignancies?

Authors:  Frédéric Pène; Márcio Soares
Journal:  Intensive Care Med       Date:  2008-01-24       Impact factor: 17.440

3.  The intensive care unit in paediatric oncology.

Authors:  D Heney; I J Lewis; L Lockwood; A T Cohen; C C Bailey
Journal:  Arch Dis Child       Date:  1992-03       Impact factor: 3.791

4.  Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit.

Authors:  Radoslaw Owczuk; Magdalena A Wujtewicz; Wioletta Sawicka; Anna Wadrzyk; Maria Wujtewicz
Journal:  Support Care Cancer       Date:  2004-12-10       Impact factor: 3.603

5.  Paediatric oncology and intensive care treatments: changing trends.

Authors:  I N Keengwe; F Stansfield; O B Eden; N D Nelhans; O R Dearlove; A Sharples
Journal:  Arch Dis Child       Date:  1999-06       Impact factor: 3.791

6.  Prognostic indicators of mortality of mechanically ventilated patients with acute leukemia in a comprehensive cancer center.

Authors:  K J Price; M Cardenas-Turanzas; H Lin; L Roden; R Nigam; J L Nates
Journal:  Minerva Anestesiol       Date:  2012-10-02       Impact factor: 3.051

7.  Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies.

Authors:  Chin Kook Rhee; Ji Young Kang; Yong Hyun Kim; Jin Woo Kim; Hyung Kyu Yoon; Seok Chan Kim; Soon Suk Kwon; Young Kyoon Kim; Kwan Hyung Kim; Hwa Sik Moon; Sung Hak Park; Hee Je Kim; Seok Lee; Jeong Sup Song
Journal:  Crit Care       Date:  2009-11-03       Impact factor: 9.097

8.  Clinical characteristics and outcomes of patients with acute myelogenous leukemia admitted to intensive care: a case-control study.

Authors:  Amanda L Roze des Ordons; Kris Chan; Imran Mirza; Derek R Townsend; Sean M Bagshaw
Journal:  BMC Cancer       Date:  2010-09-28       Impact factor: 4.430

9.  Outcome and prognostic factors in patients with hematologic malignancies admitted to the intensive care unit: a single-center experience.

Authors:  Christelle Ferrà; Pilar Marcos; Maite Misis; Mireia Morgades; María-Luisa Bordejé; Albert Oriol; Natalia Lloveras; Juan-Manuel Sancho; Blanca Xicoy; Montserrat Batlle; Jordi Klamburg; Evarist Feliu; Josep-Maria Ribera
Journal:  Int J Hematol       Date:  2007-04       Impact factor: 2.490

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.